Clinical Trial Update – Spinal Injury Project


Clinical Trial on Track For 2020

In September 2019 the Perry Cross Spinal Research Foundation announced an independent contract research organisation (CRO) has been appointed to progress a potential human clinical trial in 2020 as part of the Spinal Injury Project with Griffith University. The major research therapy is currently Australia’s greatest hope of a treatment for chronic spinal cord injuries. The appointment of an independent CRO is a major milestone for the project, as it further propels the possibility of a human clinical trial commencing next year.

Founder of the Perry Cross Spinal Research Foundation, Perry Cross, says the planned human clinical trial can’t come quick enough for the 15,000 Australians currently living with and affected by paralysis.

“We’re thrilled to see a CRO appointed to this major Australian trial and get our next steps and plan in place following it, so the goal posts we’ve set for late 2020 aren’t set back,” he said.

“The “know-how” is there, we just need to keep up the funding so this exceptional team of scientists can continue to progress the therapy.”

Read the full Media Release here. 

Read the full project outline here. 

You have the power to change a life today by helping us fund this project. It is about making the impossible, possible. Donate or register at and help us raise funds to find the cure for paralysis.

Share this great article

Newsletter Signup


Sub heading here


Share This

Select your desired option below to share a direct link to this page

Perry Cross Logo

Spinal Injury Project Research

Perry Cross Logo

LIVINWell Free Online Webinar

Register to receive your free gift
Perry Cross Logo Blk@2x

Leave a Gift in Your Will

A legacy gift to the Perry Cross Spinal Research Foundation will help us continue the journey to discover a cure for paralysis and its many complexities.

You can help people across the world to walk again. We can’t thank you enough for considering us.

Please contact us on
0457 277 579 for a confidential discussion.